Results for tag: "Jalyn"

Jalyn is a brand of prostate cancer drugs developed by GlaxoSmithKline and marketed in the United States. The drug is a combination of two active ingredients, dutasteride and tamsulosin, which work together to reduce the size of the prostate and improve urinary flow. Jalyn is used to treat symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate. It is also used to reduce the risk of acute urinary retention and the need for surgery related to BPH. Jalyn is a part of a larger market of prostate cancer drugs, which includes other brands such as Avodart, Proscar, and Uroxatral. These drugs are used to treat the symptoms of BPH, reduce the risk of acute urinary retention, and reduce the risk of prostate cancer. Some companies in the Jalyn market include GlaxoSmithKline, Merck, AstraZeneca, and Pfizer. Show Less Read more